Cetera Investment Advisers
IRMD icon

Cetera Investment Advisers’s iRadimed IRMD Stock Holding History

Cetera Investment Advisers’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$504K Sell
5,239
-212
-4% -$21.2K ﹤0.01% 3509
2025
Q4 		$530K Buy
5,451
+51
+0.9% +$4.38K ﹤0.01% 3381
2025
Q3 		$384K Buy
+5,400
New +$360K ﹤0.01% 3606

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cetera Investment Advisers's IRMD Position: Q1 2026 in Review

Cetera Investment Advisers reduced its iRadimed (IRMD) stake by 3.9% in Q1 2026, selling an estimated $21.2K and leaving 5,239 shares worth $504K. The position accounts for ﹤0.01% of the portfolio, ranked #3509.

Cetera Investment Advisers first reported a position in IRMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $530K in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Cetera Investment Advisers held 5,239 shares of iRadimed worth $504K as of Q1 2026.
  • Cetera Investment Advisers sold 212 iRadimed shares in Q1 2026, an estimated $21.2K.
  • iRadimed made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #3509 holding.
  • Cetera Investment Advisers first reported a position in iRadimed in Q3 2025 and has held it in 3 quarters since.
  • Cetera Investment Advisers's iRadimed position peaked at $530K in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.